Motivity Acquires Calmanac, Forging a Unified ABA Software Powerhouse

HONOLULU, HI – May 22, 2026 – In a significant move poised to reshape the technology landscape for Applied Behavior Analysis (ABA) therapy, Motivity announced today it has signed a definitive agreement to acquire Calmanac. The acquisition brings Calmanac’s enterprise-grade practice management system fully under the Motivity umbrella, creating a single, all-in-one platform designed to unify clinical data collection and operational management for ABA providers.

This strategic consolidation aims to address a long-standing point of friction in the ABA industry: the need for practices to juggle separate, often poorly integrated, software systems for clinical work and back-office operations. By combining Motivity’s deep expertise in clinician-led data collection with Calmanac's robust operational architecture, the unified company intends to offer a seamless solution that promises greater efficiency, improved compliance, and ultimately, better clinical outcomes.

The deal, backed by Motivity's investor Five Elms Capital, formalizes a partnership that has been years in the making and signals a new level of competition in the rapidly growing ABA software market.

A Partnership That Paved the Way

The acquisition is not an abrupt corporate marriage but the culmination of a deepening, multi-year collaboration. The relationship between Motivity and Calmanac began in 2023 with a technical integration that connected Motivity’s respected clinical data collection tools with Calmanac’s powerful practice management engine. This initial bridge allowed practices to sync crucial information related to scheduling, billing, and authorizations between the two systems.

Recognizing the potential for a more profound synthesis, Motivity took the next logical step in April 2025, formally expanding into the practice management space with Calmanac’s technology serving as its foundational framework. This extended partnership allowed the two teams to align their product roadmaps and gain a shared understanding of the market's needs. Today’s acquisition formalizes that alignment, bringing the two ABA-native teams into a single, unified organization.

"Motivity has spent more than a decade earning the trust of ABA clinicians," said Smith Anderson, CEO of Motivity. "That trust was built on one commitment: that we would never compromise clinical integrity for the sake of convenience. This acquisition is what it looks like to extend that same commitment to practice management."

Forging a Clinical-First, Enterprise-Grade Platform

The strength of the combined entity lies in the distinct, yet complementary, origins of its two components. Motivity built its reputation on a clinical-first philosophy, backed by $11 million in research funding from the National Institutes of Health (NIH). Its platform is widely chosen by Board Certified Behavior Analysts (BCBAs) for its flexible program design and real-time data capabilities, which are essential for individualized treatment.

Calmanac, conversely, was forged in the crucible of large-scale operational complexity. Its platform was originally custom-built for one of the largest and most operationally challenging ABA providers in the United States—an organization that found every other leading platform on the market fell short of its needs. Unlike systems designed for small practices and later retrofitted for scale, Calmanac was engineered from day one for enterprise-level demands. Its foundation is a rules-based architecture that standardizes and automates complex workflows, with payer compliance and credential-based scheduling architected into its core.

This union of clinical rigor and operational robustness is what Motivity believes will set its platform apart. The goal is to provide a system where clinical appropriateness and operational efficiency are not competing values but are seamlessly integrated.

Shifting the Competitive Landscape

Motivity’s acquisition of Calmanac is a calculated strategic play to challenge established leaders in the ABA software market, such as CentralReach and Rethink Behavioral Health. By creating a comprehensive, single-system solution, Motivity is now positioned to compete directly with these all-in-one providers, moving from a specialist in clinical data to a full-suite contender.

This strategy aligns with the investment philosophy of Five Elms Capital, which has backed Motivity with $27 million. The private equity firm focuses on investing in high-growth B2B software businesses, helping them become industry leaders. This acquisition is a textbook example of that strategy in action: consolidating key technologies within a specialized, high-growth vertical to create a more powerful and defensible market position. With the ABA software market projected to grow significantly in the coming years, creating a comprehensive product suite is crucial for capturing and retaining market share.

For Calmanac customers, the transition means becoming part of a larger platform with access to deeper clinical tools and a thriving user community. To ensure a smooth integration, Calmanac’s founder, Madhuri Mandaogade, will join Motivity as General Manager, bringing her team and institutional knowledge with her.

"When we built Calmanac, we built it for the ABA providers who were being underserved by platforms designed for other industries," stated Mandaogade. "Finding a partner who shares that same clinical-first philosophy wasn't guaranteed. Finding that partner in Motivity, and watching our teams align so deeply over the past year, made this the right decision."

Transforming Practice and Patient Care

Beyond the corporate strategy and market dynamics, the acquisition's ultimate promise lies in its potential impact on practitioners and the individuals they serve. The administrative burden on ABA providers is a well-known challenge, with clinicians often spending an inordinate amount of time navigating complex billing codes, managing authorizations, and reconciling data between different systems.

By unifying these functions, Motivity aims to drastically reduce this administrative load. A single platform eliminates the need for double data entry, minimizes the risk of errors when transferring information, and streamlines workflows from client intake to final payment. The integrated rules-based engine can help ensure that scheduling and billing are compliant from the start, reducing claim denials and improving revenue cycle performance.

This enhanced efficiency is not just about improving a practice's bottom line. It is about freeing up clinicians' time to focus on what matters most: delivering high-quality, data-driven care. A unified system that provides a holistic view of both clinical and operational data can lead to more informed decision-making and, ultimately, better outcomes for the families and individuals who rely on ABA services.